Functional Analysis of CDKp110 Protein Kinase
Functional Analysis of CDKp110 Protein Kinase
批准号:
7988968
负责人:
JILL M LAHTI
金额:
$11.47万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-12-17 至 2011-03-31
关键词:
Active SitesAmino Acid MotifsBiological AssayCell CycleCell divisionCellsChromatinComplexCyclin-Dependent KinasesCyclinsDefectDevelopmentEmbryoEmbryonic DevelopmentEventExhibitsGenesGenetic TranscriptionHistone H3In VitroKnock-outKnockout MiceLaboratoriesLinkMitosisMusPhenotypePhosphorylationPhosphotransferasesPhysical condensationPlayPrincipal InvestigatorProtein IsoformsProtein KinaseProteinsRNA BindingRNA Polymerase IIRNA ProcessingRNA SplicingRoleSpliceosomesStagingStaining methodStainsTestingTranscriptional Elongation FactorsTranscriptional RegulationWorkbaseblastocystcasein kinase IIdesignin vivoknockout genemRNA Precursornovelprogramsprotein functionresearch studytheoriestranscription factor TFIIFtumor
中文摘要
描述(由申请人提供):细胞分裂激酶(CDK)具有多种功能,其中大部分与细胞分裂和/或转录的控制显著相关。我们的实验室鉴定了一种新的CDK亚家族,即以前称为PITSLRE激酶的CDK 11蛋白激酶。细胞周期蛋白L1和最近的细胞周期蛋白L2是CDK 11同种型的调节伙伴。我们确定CDK 11 p110亚型是RNA聚合酶II(RNAP II)复合物的一个组成部分,这与其通过与新型RNA结合基序蛋白RBM 16相互作用影响转录延伸和潜在转录起始的能力一致。CDK 11 p110也存在于剪接体复合物中,并在前mRNA剪接事件中发挥作用。这种功能在CDK中是独特的,富含RS的一般前mRNA剪接因子RNPS 1和9 G8被鉴定为真正的相互作用因子。CDK 11 p110/p58-null小鼠胚胎不能发育超过E3.5,表明CDK 11 p110和/或CDK 11 p58激酶功能对于囊胚后胚胎发育是必需的。总之,这些研究强烈表明,CDK 11 p110激酶的功能是必不可少的正常调节转录和RNA加工过程中的细胞周期。然而,我们不知道CDK 11 p110激酶功能如何协调调节RNAP II/剪接体复合物的组成/功能。基于我们的cdc 2l基因敲除研究,CDK 11 p110/p58对于正常胚胎发育是必需的,不像其他CDK(即,除了CDK-1和-3),我们假设这些敲除小鼠的部分表型是由于CDK 11 p110的缺失,并且该蛋白质的功能是发育所必需的。为了验证这些假设,我们提出了实验来回答以下具体目标:(1)什么是功能的意义,CDK 11 p110激酶协会和/或磷酸化的RNAPII和剪接体复合物中的因素?CDK 11 p110是否在协调剪接和转录中起关键作用?(2)CK 11 p110亚型在胚胎发育中的作用是什么?如果只切除CDK 11 p110或CDK 11,是否可能获得存活胚胎?如果是这样,这些小鼠是否更容易患肿瘤或发育缺陷?
英文摘要
DESCRIPTION (provided by applicant): The cell division kinases (CDKs) have diverse functions, most of which are prominently linked to the control of cells division and/or transcription. Our laboratory identified a novel CDK subfamily, the CDK11 protein kinases previously known as the PITSLRE kinases. Cyclin L1 and, more recently, cyclin L2, are regulatory partners of the CDK 11 isoforms. We determined that the CDK11p110 isoform is a component of RNA polymerase II (RNAP II) complexes, consistent with its demonstrated ability to influence transcriptional elongation and potentially transcriptional initiation via interaction with a novel RNA-binding motif protein RBM16. CDK11p110 is also found in spliceosome complexes and has a role in pre-mRNA splicing events. This function is unique among the CDKs, with the RS-rich general pre-mRNA splicing factors RNPS1 and 9G8 identified as bona fide interactors. CDK11p110/p58-null mouse embryos fail to develop past E3.5, indicating that CDK11p110 and/or CDK11p58 kinase function is essential for post-blastocyst embryonic development. Taken together, these studies strongly suggest that CDK11p110 kinase function is essential for normal regulation of transcription and RNA processing during the cell cycle. However, we do not know how CDK11p110 kinase function might coordinately regulate the composition/function of RNAP II/spliceosome complexes. Based upon our cdc2l gene knockout studies CDK11p110/p58 is essential for normal embryonic development, unlike other CDKs (i.e., with the exception of CDKs-1 and -3), we hypothesize that a portion of the phenotype of these knockout mice is due to the absence of CDK11p110 and that the functions of the protein are required for development. To test these hypotheses we propose experiments to answer the following specific aims: (1) What is the functional significance of CDK11p110 kinase association with and/or phosphorylation of factors in RNAPII and spliceosome complexes? Does CDK11p110 play a crucial role in coordinating splicing and transcription? (2) What is the function of the CK11p110 isoform in the developing embryo? Is it possible to obtain viable embryos if only CDK11p110 or CDK11 is ablated? If so, are these mice more prone to tumors or developmental defects?
期刊论文(32)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Structure and gene expression of avian cyclin D2.
禽细胞周期蛋白D2的结构和基因表达。
DOI:
10.1016/0378-1119(95)00598-6
发表时间:
1995
期刊:
Gene
影响因子:
3.5
作者:
[Li,H, Grenet,J, Kidd,VJ]
通讯作者:
Kidd,VJ
The gene for mouse p58cdc2L1 (Cdc2l1) protein kinase maps to distal mouse chromosome 4.
小鼠 p58cdc2L1 (Cdc2l1) 蛋白激酶基因定位于小鼠 4 号远端染色体。
DOI:
10.1007/bf00352357
发表时间:
1994
期刊:
Mammalian genome : official journal of the International Mammalian Genome Society
影响因子:
--
作者:
[Mock,BA, Padlan,C, Kozak,CA, Kidd,V]
通讯作者:
Kidd,V
Chromosomal localization of a human cDNA containing a DIDS binding domain and demonstrating high homology to yeast omnipotent suppressor 45.
含有 DIDS 结合域的人类 cDNA 的染色体定位,并证明与酵母全能抑制因子 45 具有高度同源性。
DOI:
10.1007/bf01233452
发表时间:
1992
期刊:
Somatic cell and molecular genetics
影响因子:
--
作者:
[Grenett,HE, Eipers,PG, Kidd,VJ, Bounelis,P, Fuller,GM]
通讯作者:
Fuller,GM
DOI:
10.1016/s0021-9258(17)40749-6
发表时间:
1994-06
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[J. Xiang;J. Lahti;J. Grenet;J. Easton;V. Kidd]
通讯作者:
J. Xiang;J. Lahti;J. Grenet;J. Easton;V. Kidd
2-Aminopurine overrides a late telophase delay created by ectopic expression of the PITSLRE beta 1 protein kinase.
2-氨基嘌呤可以克服 PITSLRE beta 1 蛋白激酶异位表达造成的末期晚期延迟。
DOI:
10.1006/bbrc.1994.1353
发表时间:
1994
期刊:
Biochemical and biophysical research communications
影响因子:
3.1
作者:
[Xiang,J, Lahti,JM, Kidd,VJ]
通讯作者:
Kidd,VJ
共 15 条
Cytogenetics
-
批准号:8738008
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2012
-
负责人:JILL M LAHTI
-
依托单位:
Cytogenetics
-
批准号:7714160
-
项目类别:
-
资助金额:$9.33万
-
财政年份:2008
-
负责人:JILL M LAHTI
-
依托单位:
REGULATION OF CYCLIN C FUNCTION IN TUMORS & NORMAL CELLS
-
批准号:6164228
-
项目类别:
-
资助金额:$10.54万
-
财政年份:1997
-
负责人:JILL M LAHTI
-
依托单位:
REGULATION OF CYCLIN C FUNCTION IN TUMORS & NORMAL CELLS
-
批准号:2668059
-
项目类别:
-
资助金额:$9.75万
-
财政年份:1997
-
负责人:JILL M LAHTI
-
依托单位:
REGULATION OF CYCLIN C FUNCTION IN TUMORS & NORMAL CELLS
-
批准号:6362617
-
项目类别:
-
资助金额:$10.95万
-
财政年份:1997
-
负责人:JILL M LAHTI
-
依托单位:
REGULATION OF CYCLIN C FUNCTION IN TUMORS & NORMAL CELLS
-
批准号:2010643
-
项目类别:
-
资助金额:$9.38万
-
财政年份:1997
-
负责人:JILL M LAHTI
-
依托单位:
REGULATION OF CYCLIN C FUNCTION IN TUMORS & NORMAL CELLS
-
批准号:2882465
-
项目类别:
-
资助金额:$10.14万
-
财政年份:1997
-
负责人:JILL M LAHTI
-
依托单位:
Apoptotic Pathway Defects in Neuroblastoma
-
批准号:6697051
-
项目类别:
-
资助金额:$33.75万
-
财政年份:1995
-
负责人:JILL M LAHTI
-
依托单位:
Apoptotic Pathway Defects in Neuroblastoma
-
批准号:7005695
-
项目类别:
-
资助金额:$32.96万
-
财政年份:1995
-
负责人:JILL M LAHTI
-
依托单位:
Apoptotic Pathway Defects in Neuroblastoma
-
批准号:7822524
-
项目类别:
-
资助金额:$3.36万
-
财政年份:1995
-
负责人:JILL M LAHTI
-
依托单位:
Apoptotic Pathway Defects in Neuroblastoma
-
批准号:7157001
-
项目类别:
-
资助金额:$32.0万
-
财政年份:1995
-
负责人:JILL M LAHTI
-
依托单位:
The Role of Caspase-8 in Neuroblastoma Tumorigenesis
-
批准号:8136704
-
项目类别:
-
资助金额:$38.34万
-
财政年份:1995
-
负责人:JILL M LAHTI
-
依托单位:
Apoptotic Pathway Defects in Neuroblastoma
-
批准号:6835196
-
项目类别:
-
资助金额:$33.75万
-
财政年份:1995
-
负责人:JILL M LAHTI
-
依托单位:
The Role of Caspase-8 in Neuroblastoma Tumorigenesis
-
批准号:7791973
-
项目类别:
-
资助金额:$39.01万
-
财政年份:1995
-
负责人:JILL M LAHTI
-
依托单位:
Functional Analysis of CDKp110 Protein Kinase
-
批准号:7022258
-
项目类别:
-
资助金额:$27.83万
-
财政年份:1991
-
负责人:JILL M LAHTI
-
依托单位:
STRUCTURE/FUNCTION OF PITSLRE KINASES
-
批准号:6636008
-
项目类别:
-
资助金额:$24.5万
-
财政年份:1991
-
负责人:JILL M LAHTI
-
依托单位:
Functional Analysis of CDKp110 Protein Kinase
-
批准号:7212194
-
项目类别:
-
资助金额:$27.02万
-
财政年份:1991
-
负责人:JILL M LAHTI
-
依托单位:
Functional Analysis of CDKp110 Protein Kinase
-
批准号:7390316
-
项目类别:
-
资助金额:$27.02万
-
财政年份:1991
-
负责人:JILL M LAHTI
-
依托单位:
Functional Analysis of CDKp110 Protein Kinase
-
批准号:6922664
-
项目类别:
-
资助金额:$28.5万
-
财政年份:1991
-
负责人:JILL M LAHTI
-
依托单位:
Cytogenetics
-
批准号:8234118
-
项目类别:
-
资助金额:$16.23万
-
财政年份:--
-
负责人:JILL M LAHTI
-
依托单位:
海外基金